Compare H1B visa sponsorship data between Ascent Pharmaceuticals and Goldman Sachs. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
222
Ascent Pharmaceuticals
+98.4%
14,154
Goldman Sachs
Median Salary
$63,100
Ascent Pharmaceuticals
+44.3%
$113,200
Goldman Sachs
Approval Rate
100.0%
Ascent Pharmaceuticals
99.0%
Goldman Sachs
Years Sponsoring
13
Ascent Pharmaceuticals
+27.8%
18
Goldman Sachs
Historical Trends
H1B Filings Over Time
Ascent Pharmaceuticals
Goldman Sachs
Median Salary Trend
Ascent Pharmaceuticals
Goldman Sachs
Where & What They Hire
Top H1B Job Categories
Ascent Pharmaceuticals
Chemists 21 filings
Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Top H1B Work Locations
Ascent Pharmaceuticals
Central Islip, NY 21 filings
Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Year-by-Year Breakdown
| Year | Ascent Pharmaceuticals | Goldman Sachs | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | 21 | $63,100 | 100.0% | 731 | $113,200 | 99.0% |
| FY2024 | 5 | $104,700 | 100.0% | 310 | $145,000 | 100.0% |
| FY2023 | 1 | $65,000 | 100.0% | 186 | $150,000 | 100.0% |
| FY2022 | 2 | $82,000 | 100.0% | 306 | $149,000 | 100.0% |
| FY2021 | 3 | $62,000 | 100.0% | 527 | $125,000 | 100.0% |
| FY2020 | 5 | $76,000 | 100.0% | 249 | $138,000 | 100.0% |
| FY2019 | 36 | $49,500 | 100.0% | 1,726 | $115,000 | 98.7% |
| FY2018 | 23 | $52,000 | 100.0% | 1,779 | $110,000 | 98.7% |
| FY2017 | 57 | $50,000 | 100.0% | 1,085 | $103,600 | 99.0% |
| FY2016 | 24 | $49,000 | 100.0% | 1,086 | $105,050 | 98.2% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Ascent Pharmaceuticals or Goldman Sachs?
- Goldman Sachs pays higher H1B salaries with a median of $113,200 compared to Ascent Pharmaceuticals's $63,100.
- Which company sponsors more H1B visas, Ascent Pharmaceuticals or Goldman Sachs?
- Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Ascent Pharmaceuticals's 222.
- How do Ascent Pharmaceuticals and Goldman Sachs H1B approval rates compare?
- Ascent Pharmaceuticals has a 100.0% H1B approval rate while Goldman Sachs has 99.0%. Ascent Pharmaceuticals has a higher approval rate.